Exchange: NASDAQ·Updated 07:58 PM EDT

TYRA News

News
all
press releases
TYRA Stock Heads For Best Day In Nearly 10 Months — Sets Date For Key Phase 2 Bladder Cancer Drug Readout
Tyra is set to host a conference call on September 9 to discuss initial results from its Phase 2 study evaluating Dabogratinib in patients with intermediate-risk non-muscle invasive bladder cancer.
Stocktwits
More News
Tyra Biosciences to Host Conference Call on Initial Results of Oral Dabogratinib from the SURF302 Phase 2 Study for IR NMIBC on September 9, 2026
Tyra Biosciences to Host Conference Call on Initial Results of Oral Dabogratinib from the SURF302 Phase 2 Study for IR NMIBC on September 9, 2026 Tyra Biosciences to Host Conference Call on Initial Results of Oral Dabogratinib from the SURF302 Phase 2 Study for IR NMIBC on September 9, 2026 PR...
PR Newswire
Tyra Biosciences Reports Second Quarter 2026 Financial Results and Recent Highlights
Tyra Biosciences Reports Second Quarter 2026 Financial Results and Recent Highlights Tyra Biosciences Reports Second Quarter 2026 Financial Results and Recent Highlights PR Newswire CARLSBAD, Calif., Aug. 4, 2026 - Initial Ph2 data from SURF302 expected in September 2026 (n>40 enrolled to date...
PR Newswire
Is Tyra Biosciences, Inc. (TYRA) Stock a Biotech Opportunity Ahead of Key SURF302 Trial Data?
Is Tyra Biosciences, Inc. (TYRA) Stock a Biotech Opportunity Ahead of Key SURF302 Trial Data...
Yahoo! Finance: News
Wolfe Research Initiates Peer Perform rating on Tyra Biosciences, Inc. (TYRA)
Wolfe Research Initiates Peer Perform rating on Tyra Biosciences, Inc. (TYRA...
Yahoo! Finance: News
TYRA BIOSCIENCES AND BCAN ESTABLISH MAY 21 AS UPPER TRACT UROTHELIAL CANCER (UTUC) AWARENESS DAY
TYRA BIOSCIENCES AND BCAN ESTABLISH MAY 21 AS UPPER TRACT UROTHELIAL CANCER (UTUC) AWARENESS DAY TYRA BIOSCIENCES AND BCAN ESTABLISH MAY 21 AS UPPER TRACT UROTHELIAL CANCER (UTUC) AWARENESS DAY PR Newswire CARLSBAD, Calif., May 21, 2026 -Collaboration aims to raise awareness of UTUC and the need...
PR Newswire
Tyra Biosciences Stock Has Soared 280% in a Year. One Fund Just Disclosed Buying More Shares
Tyra Biosciences Stock Has Soared 280% in a Year. One Fund Just Disclosed Buying More Shares...
Yahoo! Finance: News
Tyra Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights
Tyra Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights Tyra Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights PR Newswire CARLSBAD, Calif...
PR Newswire
Tyra Biosciences to Participate in Upcoming Investor Conferences
Tyra Biosciences to Participate in Upcoming Investor Conferences Tyra Biosciences to Participate in Upcoming Investor Conferences PR Newswire CARLSBAD, Calif., May 7, 2026 CARLSBAD, Calif., May 7...
PR Newswire
Growth Stocks To Follow Now - May 4th
Prologis, Pershing Square, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, Hercules Capital, and Tyra Biosciences are the seven Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to grow their revenues and earnings...
MarketBeat

Advertisement|Remove ads.